Eisai Sues To Protect Popular Alzheimer's Treatment
A Tokyo-based drug company has filed a federal patent suit to protect its billion-dollar Alzheimer's treatment Aricept ODT from generic competition....To view the full article, register now.
Already a subscriber? Click here to view full article